EUVIMEDEUVIMED entdecken
Open Access

Risk factors associated with mortality in hospitalized patients with laboratory confirmed SARS-CoV-2 infection during the period of omicron (B.1.1.529) variant predominance

Ashley L O'Leary, Bethany A Wattengel, Michael T Carter, Alexandra F Drye, Kari A Mergenhagen

American Journal of Infection Control · 2023-06 · 51 (6) · 603-606

DOI: 10.1016/j.ajic.2022.08.033 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Infection Control, 2023-06. Verfasst von Ashley L O'Leary und 4 weiteren Autor:innen. Beteiligte Einrichtung: Veteran Affairs Western New York Healthcare System, Department of Pharmacy, Buffalo, NY. Hauptthemen laut MEDLINE: COVID-19. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 13 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: SARS-CoV-2 Omicron variant has a high transmission rate. In December 2021, Omicron became the dominant variant and quickly accounted for majority of infections in the United States. Drug shortages have led to prioritization of patients for COVID-19 treatment based on risk factors for severe disease. METHODS: A retrospective analysis of hospitalized patients with COVID-19 infection at Veteran Affairs Healthcare System across the United States. The primary outcome was 14-day all-cause mortality after the first documented positive SARS-CoV-2 laboratory test. Odds ratios were generated from a multivariate logistic regression of significant factors. RESULTS: This study included 12,936 COVID-19 inpatients during a period of Omicron predominance. Age ≥ 65 years is a predictor of 14-day mortality among the vaccinated and unvaccinated population (OR 4.05, CI 3.06-5.45, P ≤ .0001). Triple vaccinated patients demonstrated a 52% decreased risk of death with COVID-19 infection (OR 0.48, CI 0.37-0.61, P ≤ .0001). Patients who were double vaccinated had a 39% decreased risk of death with COVID-19 infection (OR 0.61, CI 0.46-0.80, P = .003). CONCLUSION: Advanced age ≥ 65 is the greatest risk factor for mortality in hospitalized COVID-19 patients. COVID-19 vaccination, especially booster doses, was associated with a decreased risk of 14-day mortality compared to double vaccinated or non-vaccinated patients. Results of this study suggest that advanced age should be considered first for prioritization of COVID-19 treatments for Omicron.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19HumansAgedSARS-CoV-2COVID-19 Drug TreatmentCOVID-19 VaccinesRetrospective StudiesInpatientsRisk Factors

Stichwörter der Autor:innen

COVID-19MortalityVaccination

Substanzen

COVID-19 Vaccines

Autor:innen und Institutionen

  • Veteran Affairs Western New York Healthcare System, Department of Pharmacy, Buffalo, NY.
  • Veteran Affairs Western New York Healthcare System, Department of Pharmacy, Buffalo, NY. Electronic address: Kari.Mergenhagen@va.gov.

Zitieren

APA

O'Leary, A. L., Wattengel, B. A., Carter, M. T., Drye, A. F., & Mergenhagen, K. A. (2023). Risk factors associated with mortality in hospitalized patients with laboratory confirmed SARS-CoV-2 infection during the period of omicron (B.1.1.529) variant predominance. American Journal of Infection Control, 51(6), 603-606. https://doi.org/10.1016/j.ajic.2022.08.033

Vancouver

O'Leary AL, Wattengel BA, Carter MT, Drye AF, Mergenhagen KA. Risk factors associated with mortality in hospitalized patients with laboratory confirmed SARS-CoV-2 infection during the period of omicron (B.1.1.529) variant predominance. American Journal of Infection Control. 2023;51(6):603-606. doi:10.1016/j.ajic.2022.08.033

BibTeX
@article{OLeary2023,
  author = {O'Leary, Ashley L and Wattengel, Bethany A and Carter, Michael T and Drye, Alexandra F and Mergenhagen, Kari A},
  title = {Risk factors associated with mortality in hospitalized patients with laboratory confirmed SARS-CoV-2 infection during the period of omicron (B.1.1.529) variant predominance},
  journal = {American Journal of Infection Control},
  year = {2023},
  volume = {51},
  number = {6},
  pages = {603--606},
  doi = {10.1016/j.ajic.2022.08.033}
}
Kostenlos starten →